SMS Lifesciences Stock Screener | Share Price & Fundamental Analysis
SMSLIFE
Pharmaceuticals
Screen SMS Lifesciences share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹1353.50
▼
-84.40 (-5.87%)
Share Price BSE
₹1348.75
▼
-84.20 (-5.88%)
Market Cap
₹354.00 Cr.
P/E Ratio (TTM)
22.27
P/B Ratio
1.82
EPS (TTM)
₹66.51
Dividend Yield
0.13%
Debt to Equity
0.50
52W High
₹1659.70
52W Low
₹1044.65
Operating Margin
8.00%
Profit Margin
4.35%
Revenue (TTM)
₹92.00
EBITDA
₹10.00
Net Income
₹4.00
Total Assets
₹390.00
Total Equity
₹212.00
SMS Lifesciences Share Price History - Stock Screener Chart
Screen SMSLIFE historical share price movements with interactive charts. Analyze price trends and patterns.
SMS Lifesciences Company Profile - Fundamental Screener
Screen SMS Lifesciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SMSLIFE shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE320X01016
SMS Lifesciences Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen SMSLIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 390 | 391 | 395 | 357 | 302 | 253 | 270 |
| Current Assets | 151 | 156 | 159 | 156 | 126 | 107 | 142 |
| Fixed Assets | 232 | 223 | 228 | 142 | 130 | 124 | 119 |
| Liabilities | |||||||
| Total Liabilities | 390 | 391 | 395 | 357 | 302 | 253 | 270 |
| Current Liabilities | 36 | 52 | 73 | 56 | 59 | 50 | 39 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 212 | 194 | 188 | 165 | 129 | 116 | 106 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves & Surplus | 194 | 174 | 166 | 149 | 126 | 113 | 103 |
Screen SMSLIFE income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec | 2021-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 92 | 84 | 92 | 93 | 81 | 85 | 69 | 75 | 70 | 73 | 102 | 83 | 81 | 89 | 84 |
| Expenses | 82 | 71 | 79 | 76 | 70 | 72 | 62 | 72 | 61 | 63 | 89 | 74 | 73 | 79 | 74 |
| EBITDA | 10 | 13 | 14 | 17 | 11 | 13 | 7 | 3 | 8 | 10 | 13 | 9 | 8 | 10 | 10 |
| Operating Profit % | 8.00% | 14.00% | 13.00% | 18.00% | 11.00% | 15.00% | 4.00% | 3.00% | 11.00% | 13.00% | 7.00% | 10.00% | 10.00% | 11.00% | 10.00% |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 2 |
| Interest | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 1 |
| Profit Before Tax | 4 | 7 | 7 | 11 | 5 | 7 | 2 | -3 | 2 | 4 | 9 | 5 | 4 | 6 | 7 |
| Tax | 1 | 3 | 1 | 4 | 1 | 2 | 0 | 1 | 2 | 0 | 1 | 2 | 1 | 2 | 2 |
| Net Profit | 4 | 4 | 7 | 7 | 3 | 5 | 2 | -4 | 0 | 4 | 8 | 2 | 3 | 4 | 5 |
| EPS | 9.83 | 13.75 | 19.53 | 23.15 | 15.46 | 18.08 | 5.66 | -5.94 | 2.20 | 14.24 | 26.00 | 9.95 | 9.10 | 13.18 | 16.72 |
SMS Lifesciences Cash Flow Screener - Liquidity Fundamentals
Screen SMSLIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | 34 | 24 | 15 | -11 | 35 | 15 | 30 |
| Investing Activities | -15 | -19 | -31 | -7 | -26 | -27 | -44 |
| Financing Activities | -19 | -7 | 17 | 11 | -3 | 12 | 15 |
| Net Cash Flow | 0 | -1 | 0 | -8 | 6 | 0 | 1 |
Screen SMSLIFE shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 71.41% | 71.41% | 71.41% | 71.19% | 71.41% | 71.41% | 71.41% | 70.32% |
| FII Holding | 0.00% | 0.03% | 0.00% | 0.00% | 0.01% | 0.02% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 25.55% | 25.55% | 25.32% | 25.64% | 25.56% | 25.56% | 25.51% | 25.98% |
| Other Holding | 3.04% | 3.01% | 3.25% | 3.17% | 3.02% | 3.01% | 3.08% | 3.69% |
| Shareholder Count | 7,479 | 7,412 | 7,521 | 8,116 | 7,861 | 7,849 | 7,626 | 8,349 |
SMS Lifesciences Dividend Screener - Share Yield Analysis
Screen SMSLIFE dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹1.50 | 0.13% |
| 2024-March | ₹1.50 | 0.14% |
| 2023-March | ₹1.50 | 0.22% |
| 2022-March | ₹1.50 | 0.29% |
| 2021-March | ₹1.50 | 0.21% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹1.50 | 0.84% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
SMS Lifesciences Index Membership - Market Screener Classification
Screen SMSLIFE by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
SMS Lifesciences Market Events Screener - Corporate Actions
Screen SMSLIFE market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 1.81% | ||
| Dividend | ₹ 1.50 /share | 16.44% | ||
| Dividend | ₹ 1.50 /share | 8.83% | ||
| Dividend | ₹ 1.50 /share | -8.24% | ||
| Dividend | ₹ 1.50 /share | 130.55% | ||
| Annual General Meeting | NA | 55.04% | ||
| Dividend | ₹ 1.50 /share | -10.95% | ||
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | -2.64% |
| 2025-08-11 | 2025-08-11 | Quarterly Result Announcement | NA | -6.75% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 4.87% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -6.46% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -10.06% |
| 2016-06-22 | 2016-06-22 | Change Of Name | NA | - |
SMS Lifesciences Competitors Screener - Peer Comparison
Screen SMSLIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 405,824 | 38.74 | 54,729 | 9.71% | 10,980 | 57.82 |
| Divis Laboratories | 176,709 | 71.11 | 9,712 | 18.67% | 2,191 | 59.81 |
| Cipla | 121,624 | 22.36 | 28,410 | 7.12% | 5,291 | 42.33 |
| Torrent Pharmaceuticals | 121,164 | 60.51 | 11,539 | 6.99% | 1,911 | 70.23 |
| Dr Reddys Laboratories | 100,604 | 17.53 | 33,741 | 16.73% | 5,725 | 35.45 |
| Zydus Life Science | 94,999 | 18.88 | 23,511 | 18.55% | 4,615 | 35.94 |
| Mankind Pharma | 93,358 | 52.66 | 12,744 | 20.90% | 2,007 | 23.38 |
| Lupin | 90,063 | 20.71 | 22,910 | 13.74% | 3,306 | 56.75 |
| Alkem Laboratories | 67,775 | 29.08 | 13,458 | 3.70% | 2,216 | 64.68 |
| Aurobindo Pharma | 65,271 | 19.24 | 32,346 | 9.43% | 3,484 | 61.48 |
SMS Lifesciences Company Announcements - News Screener
Screen SMSLIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| Board Meeting Outcome for For The Meeting Held On November 10 2025 | View | |
| 2025-11-23 | Temporary Withholding Of Dividend | View |
| 2025-11-21 | Report (Special Window) | View |
| 2025-11-20 | Board Meeting Intimation for 95Th Board Meeting (10.11.2025) | View |
| 2025-10-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-12 | Report (Special Window) | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-29 | Update (Material Subsidiary) | View |
| 2025-09-26 | ANVISA Inspection | View |
| 2025-09-20 | Closure of Trading Window | View |
| 2025-09-15 | Report (Special Window) | View |
| 2025-09-09 | Annual Report (Weblink) | View |
| 2025-09-06 | Newspaper Advertisement (AGM Notice) | View |
| 2025-09-06 | Reg. 34 (1) Annual Report. | View |
| 2025-09-06 | AGM Notice (Sept 30 2025) | View |
| 2025-08-28 | Record Date (Dividend) | View |
| 2025-08-26 | Events Calendar (AGM) | View |
| 2025-08-21 | Announcement under Regulation 30 (LODR)-Change of Company Name | View |
| 2025-08-12 | Newspaper Publication (Financial Results) | View |